US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist
  • 6.340
  • +0.460+7.82%
Close Nov 27 16:00 ET
  • 6.360
  • +0.020+0.32%
Post 16:33 ET
538.51MMarket Cap-5372P/E (TTM)

Terns Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Terns Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Terns Pharmaceuticals Earnings Reports

  • Terns Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:48 ET

  • Terns Pharmaceuticals | 8-K: Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates

    Nov 12 16:20 ET

  • Terns Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 5 17:03 ET

  • Terns Pharmaceuticals | 8-K: Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates

    Aug 5 16:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 27, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data